Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New bone graft aims to ease pain from spine fractures

NCT ID NCT07561489

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a bone graft implant called OsteoPearl in 25 adults aged 50 and older who have a spinal compression fracture. The implant is placed during a standard procedure to stabilize the fracture. Researchers will track pain and quality of life over 30 days to see if the implant helps reduce pain and improve recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
OsteoPearl Biological Allograft (a bone graft implant)
What this could lead to
If it works, this could provide a new option to reduce pain and improve recovery for older adults with spinal fractures.
What could go wrong
This is a small, early observational study with only 25 participants and no comparison group, so results may not apply widely. Pain relief may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 25 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients undergoing a standard of care kyphoplasty or vertebroplasty procedure.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Skeletally mature adult ≥ 50 years of age at the time of surgery; 2. Currently in an independent living environment; 3. One- or two- level, acute (within twelve weeks of injury), thoracic or lumbar (T5-L5) vertebral body compression fracture(s) with evidence of marrow edema by MRI; 4. Adequate vertebral body height and geometry for insertion of the access instruments, as determined by the investigator and suitable candidate for standard kyphoplasty or vertebroplasty procedure; 5. NRS back pain score ≥ 7 on a 0-10 scale; 6. Has central pain over the spinous process upon palpation at the planned vertebral index level; 7. Psychosocially, mentally and physically able to fully comply with this protocol including adhering to scheduled visits, treatment plan, completing forms, and other study procedures; 8. Personally signed and dated informed consent document prior to any study-related procedures indicating that the participant has been informed of all pertinent aspects of the study. Exclusion Criteria: 1. More than two levels with a vertebral compression fracture; 2. Previous treated or untreated vertebral compression fractures; 3. Uncorrectable coagulopathy; 4. Previous instrumented spinal surgery; 5. Significant vertebral collapse defined as \> 70% of original vertebral height, or a burst, or pedicle fracture; 6. Degenerative scoliosis, defined as Cobb angle \> 20° at any level; 7. Pre-existing neurological deficit or radicular pain that is not well defined or unstable; 8. Disabling back pain secondary to causes other than acute fracture; 9. Inability to walk or stand prior to sustaining the vertebral compression fracture; 10. Active systemic or local infection; 11. Known history of Paget's disease, osteomalacia, or any other metabolic bone disease other than osteopenia or osteoporosis; 12. Morbid obesity defined as a body mass index \> 40 kg/m2; 13. Active malignancy. A participant with a history of any invasive malignancy (except non-melanoma skin cancer), unless treated with curative intent and there has been no clinical signs or symptoms of the malignancy for more than 5 years; 14. Current or recent history (within last 2 years) of substance abuse (e.g., recreational drugs, narcotics, or alcohol); 15. Currently involved in study of another investigational product that may affect outcome; 16. History of psychosocial disorders that could prevent accurate completion of self-reporting assessment scales; 17. Pregnant or planning to become pregnant during the study period; 18. Involved in active spinal litigation; 19. Involved in a workers compensation case; 20. Prisoner or ward of the state; 21. Unable to undergo a MRI/CT procedure.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Allograft are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Atlas Surgery Center

    Williamsville, New York, 14221, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.